{
    "nctId": "NCT04787029",
    "briefTitle": "Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study",
    "officialTitle": "Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "The cumulative incidence rate of lymphedema (%)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients who underwent radical mastectomy and sentinel lymphctomy or axillary lymphectomy after diagnosis of unilateral breast cancer\n2. Patients who are scheduled for adjuvant chemotherapy including Docetaxel after surgery\n3. Patients aged 19 to 70\n4. Patients who can understand the contents of this study and obtain consent\n\nExclusion Criteria:\n\n1. Patients with a history of breast-related surgery prior to this breast cancer surgery\n2. Patients with metastases to other organs\n3. Patients who have undergone neoadjuvant chemotherapy or have previously received radiation therapy\n4. Patients with systemic diseases that may not be able to conduct clinical research\n5. Patients with skin diseases who cannot receive medical compression treatment",
    "sex": "ALL",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}